For the quarter ended August 2025, Paychex (PAYX) reported revenue of $1.54 billion, up 16.8% over the same period last year. EPS came in at $1.22, compared to $1.16 in the year-ago quarter.The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $1.54 billion. With the consensus EPS estimate being $1.21, the EPS surprise was +0.83%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their nex ...

Core Insights - Integra LifeSciences reported revenue of $415.61 million for the quarter ended June 2025, reflecting a year-over-year decline of 0.6% and an EPS of $0.45 compared to $0.63 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $395.64 million by 5.05%, and the EPS also surpassed the consensus estimate of $0.43 by 4.65% [1] Revenue Performance - Organic Revenue Growth was -1.4%, better than the average estimate of -6.3% based on four analysts [4] - Codman Specialty Surgical revenue totaled $303.96 million, exceeding the average estimate of $294.18 million by four analysts, representing a year-over-year change of +0.7% [4] - Tissue Technologies revenue was $111.65 million, compared to the estimated $101.48 million, showing a year-over-year decline of -4.1% [4] - Wound Reconstruction and Care revenue within Tissue Technologies was $84.75 million, surpassing the average estimate of $80.24 million, with a year-over-year change of -3.4% [4] - Private Label revenue in Tissue Technologies was $26.9 million, exceeding the two-analyst average estimate of $25.3 million, reflecting a year-over-year decline of -6.3% [4] Stock Performance - Shares of Integra have returned -8.5% over the past month, contrasting with the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how EQT performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: View all Key Company Metrics for EQT here>>> For the quarter ended June 2025, EQT Corporation (EQT) reported revenue of $1.6 billion, up 35.2% over ...

Core Insights - Cogent Communications reported revenue of $247.05 million for Q1 2025, reflecting a year-over-year decline of 7.2% and an EPS of -$1.09, an improvement from -$1.29 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $250.18 million by 1.25%, while the EPS was also below the consensus estimate of -$1.05 by 3.81% [1] Financial Performance Metrics - Total customer connections were 120,731, below the average estimate of 124,494 [4] - On-net customer connections were 86,781, compared to the estimate of 87,842 [4] - Off-net customer connections were 27,508, below the estimate of 30,698 [4] - Non-core customer connections were 5,120, compared to the estimate of 5,576 [4] - Total on-net buildings reached 3,500, slightly below the estimate of 3,481 [4] Revenue Breakdown - Corporate revenue was $110.69 million, down 11.4% year-over-year, and below the estimate of $111.50 million [4] - Enterprise revenue was $43.75 million, a decline of 11.3% year-over-year, compared to the estimate of $44.93 million [4] - Net-centric revenue was $92.62 million, showing a slight increase of 0.7% year-over-year, but below the estimate of $93.76 million [4] - Wavelength revenue surged to $7.12 million, a significant increase of 114% year-over-year, but below the estimate of $8.03 million [4] - Non-core service revenue was $3.03 million, a drastic decline of 49.9% year-over-year, compared to the estimate of $3.58 million [4] - On-net service revenue was $129.63 million, down 6.5% year-over-year, slightly below the estimate of $130.42 million [4] - Off-net service revenue was $107.27 million, down 9.2% year-over-year, compared to the estimate of $108.95 million [4] Stock Performance - Cogent's shares have returned -1.2% over the past month, contrasting with the Zacks S&P 500 composite's increase of 11.3% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]